aCancer Control Department, Paoli-Calmettes Institute
bAix Marseille University, UMR_S912, IRD
cINSERM, UMR912 (SESSTIM), Marseille
dCoordination Center for Cancer Screening, Bretonneau University Hospital, Tours
eKantar Health, Montrouge
fPorte de Saint-Cloud Clinic, Boulogne-Billancourt
gRoche, Boulogne-Billancourt
hDepartment of Medical Oncology, Jean Minjoz University Hospital, Inserm U645, Besançon
iLéon Bérard Cancer Centre, Lyon
jDepartment of Oncology and Hematology, Paul-Brousse University Hospital, Inserm U1004, Villejuif, France
Correspondence to François Eisinger MD, PhD, Cancer Control Department, Paoli-Calmettes Institute, 232 Bd Saint-Marguerite, 13009 Marseille, France Tel: +33 491 22 35 41; fax: +33 491 22 38 57; e-mail: [email protected]
Received February 16, 2015
Accepted February 18, 2015